Cybin: Psilocybin Trial Participants Experience Nearly 80% Reduction in Depression Symptoms

January 4, 2024

Beckley Psytech Secures $50 Million Investment from atai to Advance Short-Duration Psychedelic Therapies

January 4, 2024

Navigating the Psychedelic Renaissance: The Intersection of Medicine, Spirituality and Big Business

January 3, 2024

MindBio Therapeutics Reports Progress on LSD Trial for Depression

December 21, 2023

Compass Pathways Psilocybin Trial Shows 80% Remission Rate in Bipolar II Disorder

December 7, 2023